Cargando…

Type 2 diabetes in midlife and risk of cerebrovascular disease in late life: a prospective nested case−control study in a nationwide Swedish twin cohort

AIMS/HYPOTHESIS: We aimed to examine the association between midlife type 2 diabetes mellitus and cerebrovascular disease (CBD) in late life, and further to explore whether genetic and early-life familial environmental factors (such as shared childhood socioeconomic status and adolescent environment...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Rongrong, Pedersen, Nancy L., Bao, Cuiping, Xu, Weige, Xu, Hui, Song, Ruixue, Qi, Xiuying, Xu, Weili
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647245/
https://www.ncbi.nlm.nih.gov/pubmed/31172222
http://dx.doi.org/10.1007/s00125-019-4892-3
_version_ 1783437689053249536
author Yang, Rongrong
Pedersen, Nancy L.
Bao, Cuiping
Xu, Weige
Xu, Hui
Song, Ruixue
Qi, Xiuying
Xu, Weili
author_facet Yang, Rongrong
Pedersen, Nancy L.
Bao, Cuiping
Xu, Weige
Xu, Hui
Song, Ruixue
Qi, Xiuying
Xu, Weili
author_sort Yang, Rongrong
collection PubMed
description AIMS/HYPOTHESIS: We aimed to examine the association between midlife type 2 diabetes mellitus and cerebrovascular disease (CBD) in late life, and further to explore whether genetic and early-life familial environmental factors (such as shared childhood socioeconomic status and adolescent environment) play a role in this association. METHODS: In this prospective nested case−control study based on the Swedish Twin Registry, 33,086 twin individuals who were born in 1958 or earlier and were CBD-free before the age of 60 were included. Midlife (40–59 years) type 2 diabetes was ascertained from self-report, the National Patient Registry (NPR) and glucose-lowering medication use. CBD diagnosis (cerebral infarction, occlusion of cerebral arteries, subarachnoid haemorrhage, intracerebral haemorrhage and unspecified CBD) and onset age were identified from the NPR. Late-life CBD was defined as CBD onset age ≥60 years. Generalised estimating equation (GEE) models were used to analyse unmatched case−control data (adjusted for the clustering of twins within a pair). Conditional logistic regression was used in co-twin matched case−control analyses in CBD-discordant twin pairs. RESULTS: Of all the participants, 1248 (3.8%) had midlife type 2 diabetes and 3121 (9.4%) had CBD in late life. In GEE models adjusted for age, sex, education, BMI, smoking, alcohol consumption, marital status, hypertension and heart disease, the ORs (95% CIs) of type 2 diabetes were 1.29 (1.03, 1.61) for cerebral infarction, 2.03 (1.20, 3.44) for occlusion of cerebral arteries, 0.52 (0.12, 2.21) for subarachnoid haemorrhage and 0.78 (0.45, 1.36) for intracerebral haemorrhage. In multi-adjusted conditional logistic regression, the OR of the type 2 diabetes–cerebral infarction association was 0.96 (0.51, 1.80). The differences in ORs from the GEE and co-twin control analyses were not statistically significant (p = 0.780). CONCLUSIONS/INTERPRETATION: Midlife type 2 diabetes is significantly associated with increased risk of cerebral infarction and occlusion of cerebral arteries, but not intracerebral haemorrhage or subarachnoid haemorrhage in late life. Genetic and early-life familial environmental factors do not appear to account for the type 2 diabetes–cerebral infarction association, but further clarification is needed. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00125-019-4892-3) contains peer-reviewed but unedited supplementary material, which is available to authorised users.
format Online
Article
Text
id pubmed-6647245
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-66472452019-08-06 Type 2 diabetes in midlife and risk of cerebrovascular disease in late life: a prospective nested case−control study in a nationwide Swedish twin cohort Yang, Rongrong Pedersen, Nancy L. Bao, Cuiping Xu, Weige Xu, Hui Song, Ruixue Qi, Xiuying Xu, Weili Diabetologia Article AIMS/HYPOTHESIS: We aimed to examine the association between midlife type 2 diabetes mellitus and cerebrovascular disease (CBD) in late life, and further to explore whether genetic and early-life familial environmental factors (such as shared childhood socioeconomic status and adolescent environment) play a role in this association. METHODS: In this prospective nested case−control study based on the Swedish Twin Registry, 33,086 twin individuals who were born in 1958 or earlier and were CBD-free before the age of 60 were included. Midlife (40–59 years) type 2 diabetes was ascertained from self-report, the National Patient Registry (NPR) and glucose-lowering medication use. CBD diagnosis (cerebral infarction, occlusion of cerebral arteries, subarachnoid haemorrhage, intracerebral haemorrhage and unspecified CBD) and onset age were identified from the NPR. Late-life CBD was defined as CBD onset age ≥60 years. Generalised estimating equation (GEE) models were used to analyse unmatched case−control data (adjusted for the clustering of twins within a pair). Conditional logistic regression was used in co-twin matched case−control analyses in CBD-discordant twin pairs. RESULTS: Of all the participants, 1248 (3.8%) had midlife type 2 diabetes and 3121 (9.4%) had CBD in late life. In GEE models adjusted for age, sex, education, BMI, smoking, alcohol consumption, marital status, hypertension and heart disease, the ORs (95% CIs) of type 2 diabetes were 1.29 (1.03, 1.61) for cerebral infarction, 2.03 (1.20, 3.44) for occlusion of cerebral arteries, 0.52 (0.12, 2.21) for subarachnoid haemorrhage and 0.78 (0.45, 1.36) for intracerebral haemorrhage. In multi-adjusted conditional logistic regression, the OR of the type 2 diabetes–cerebral infarction association was 0.96 (0.51, 1.80). The differences in ORs from the GEE and co-twin control analyses were not statistically significant (p = 0.780). CONCLUSIONS/INTERPRETATION: Midlife type 2 diabetes is significantly associated with increased risk of cerebral infarction and occlusion of cerebral arteries, but not intracerebral haemorrhage or subarachnoid haemorrhage in late life. Genetic and early-life familial environmental factors do not appear to account for the type 2 diabetes–cerebral infarction association, but further clarification is needed. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00125-019-4892-3) contains peer-reviewed but unedited supplementary material, which is available to authorised users. Springer Berlin Heidelberg 2019-06-05 2019 /pmc/articles/PMC6647245/ /pubmed/31172222 http://dx.doi.org/10.1007/s00125-019-4892-3 Text en © The Author(s) 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Article
Yang, Rongrong
Pedersen, Nancy L.
Bao, Cuiping
Xu, Weige
Xu, Hui
Song, Ruixue
Qi, Xiuying
Xu, Weili
Type 2 diabetes in midlife and risk of cerebrovascular disease in late life: a prospective nested case−control study in a nationwide Swedish twin cohort
title Type 2 diabetes in midlife and risk of cerebrovascular disease in late life: a prospective nested case−control study in a nationwide Swedish twin cohort
title_full Type 2 diabetes in midlife and risk of cerebrovascular disease in late life: a prospective nested case−control study in a nationwide Swedish twin cohort
title_fullStr Type 2 diabetes in midlife and risk of cerebrovascular disease in late life: a prospective nested case−control study in a nationwide Swedish twin cohort
title_full_unstemmed Type 2 diabetes in midlife and risk of cerebrovascular disease in late life: a prospective nested case−control study in a nationwide Swedish twin cohort
title_short Type 2 diabetes in midlife and risk of cerebrovascular disease in late life: a prospective nested case−control study in a nationwide Swedish twin cohort
title_sort type 2 diabetes in midlife and risk of cerebrovascular disease in late life: a prospective nested case−control study in a nationwide swedish twin cohort
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647245/
https://www.ncbi.nlm.nih.gov/pubmed/31172222
http://dx.doi.org/10.1007/s00125-019-4892-3
work_keys_str_mv AT yangrongrong type2diabetesinmidlifeandriskofcerebrovasculardiseaseinlatelifeaprospectivenestedcasecontrolstudyinanationwideswedishtwincohort
AT pedersennancyl type2diabetesinmidlifeandriskofcerebrovasculardiseaseinlatelifeaprospectivenestedcasecontrolstudyinanationwideswedishtwincohort
AT baocuiping type2diabetesinmidlifeandriskofcerebrovasculardiseaseinlatelifeaprospectivenestedcasecontrolstudyinanationwideswedishtwincohort
AT xuweige type2diabetesinmidlifeandriskofcerebrovasculardiseaseinlatelifeaprospectivenestedcasecontrolstudyinanationwideswedishtwincohort
AT xuhui type2diabetesinmidlifeandriskofcerebrovasculardiseaseinlatelifeaprospectivenestedcasecontrolstudyinanationwideswedishtwincohort
AT songruixue type2diabetesinmidlifeandriskofcerebrovasculardiseaseinlatelifeaprospectivenestedcasecontrolstudyinanationwideswedishtwincohort
AT qixiuying type2diabetesinmidlifeandriskofcerebrovasculardiseaseinlatelifeaprospectivenestedcasecontrolstudyinanationwideswedishtwincohort
AT xuweili type2diabetesinmidlifeandriskofcerebrovasculardiseaseinlatelifeaprospectivenestedcasecontrolstudyinanationwideswedishtwincohort